David W. Meline
Independent Director
Company leadership profile.
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufact...
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
Independent Director
Company leadership profile.
Independent Director
Company leadership profile.
Independent Chairman
Company leadership profile.
Lead Independent Director
Company leadership profile.
Independent Director
Company leadership profile.
Independent Director
Company leadership profile.
Independent Director
Company leadership profile.
Director
Company leadership profile.
Director
Company leadership profile.
Director
Company leadership profile.
1 expert evaluated Lonza Group.
Explore the public profiles of experts who have evaluated this project.
Orbitrum Academy